Goodwin Procter LLP advised Centerview Partners on the deal. Centerview Partners acted as financial advisor to Immunomedics, Inc. (NASDAQ: IMMU), on the definitive agreement pursuant to…
This content is for Standard 1 Year members only. LoginJoin Now
Author: Ambrogio Visconti
…
This content is for Standard 1 Year members only. LoginJoin Now